Mouse Lipoteichoic Acid Monoclonal Antibody

Lipoteichoic Acid, mAb 55

Cat. Num. AAA584825

• Applications: Flow Cytometry, Functional Assay, Immunohistochemistry, Immunofluorescence, Western Blot
• Synonyms: Lipoteichoic Acid; Monoclonal Antibody; mAb 55; anti-Lipoteichoic Acid antibody

• Host: Mouse
• Clonality: Monoclonal
• Form/Format: 1 ml (100 mug/ml) 0.2 mum filtered antibody solution in PBS, containing 0.1% bovine serum albumin and 0.02% sodium azide.; For unit size 0.5 mg or larger: PBS only (concentration< 0.5mg/ml)

• Applicable Applications for anti-Lipoteichoic Acid antibody: Flow Cytometry (FC/FACS), Immunohistochemistry (IHC) Formalin, Immunoassay, Immunofluorescence (IF), Western Blot (WB)
• Preparation and Storage: Should be stored at 4 degree C.; Under recommended storage conditions, product is stable for one year.

Related Product Information for anti-Lipoteichoic Acid antibody

The monoclonal antibody 55 recognizes lipoteichoic acid (LTA). LTA, a glycerol phosphate surface polymer, is a component of the envelope of Gram-positive bacteria. LTA is anchored via its glycolipids to the membrane and carries a polysaccharide chain extending into the peptidoglycan layer of the cell wall. LTA is released spontaneously into the culture medium during growth of gram-positive bacteria. LTA functions as an immune activator with characteristics very similar to lipopolysaccharide (LPS) from Gram-negative bacteria. LTA binds to CD14 and triggers activation predominantly via Toll-like receptor 2. Although LTA is internalized and traffics to the Golgi, the cellular activation in response to LTA occurs at the cell surface.

Product Categories/Family for anti-Lipoteichoic Acid antibody

Infectious Diseases

References

1. Hogg,S et al; Occurrence of lipotechoic acid in oral streptococci. Int. journal of systematic bacteriology 1997, 47:62. 2. Langevelde, P et al; Antibiotic-induced release of lipoteichoic acid and peptidoglycan from Staphylococcus aureus: Quantitative measurements and biological reactivities. Antimicrob Agents Chemother 1998, 42: 3073. 3. Langevelde, P et al; Antibiotic-induced cell wall fragments of Staphylococcus aureus increase endothelial chemokine secretion and adhesiveness for granulocytes. Antimicrob Agents Chemother 1999, 43: 2984. 4. Triantafilou, M et al; Lipoteichoic acid and toll-like receptor 2 internalization and targeting to the golgi are lipid raft-dependent. J Biol Chem 2004, 279: 40882. 5. Henneke, P et al; Role of lipoteichoic acid in the phagocyte response to group B Streptococcus. J Immunol 2005, 174: 6449. 6. Grundling, A et al. Synthesis of glycerol phosphate lipoteichoic acid in Staphylococcus aureus. PNAS 2007, 104:8478. 7. Jimenez-Dalmaroni, M et al. Soluble CD36 ectodomain binds negatively charged diacylglycerol ligands and acts as a co-receptor for TLR2. Plos One 2009, 4:7411. 8. Yajima, A et al. Contribution of phosphoglucosamine mutase to the resistance of Streptococcus gordonii DL1 to polymorphonuclear leukocyte killing. FEMS Microbiol lett 2009, 297: 196. 9. Hashimoto, Y et al. Identification of LTA as a ligand for draper in the phagocytosis of Staphylococcus aureus by Drosophila hemocytes. I.Immunol 2009, 183:7451. 10. Hirose, Y et al. Lipoteichoic acids on lactobacillus platarum cell surfaces correlate with induction of interleukin-12p40 production. Microbiol immunol 2010, 54:143. 11. Wormann, M.E. et al. Enzymatic activities and functional interdependencies of Bacillus subtilis lipoteichoic acid synthesis enzymes. Molecular Microbiology 2011, 79: 566. 12. Palomino, M.M. et al Osmotic stress adaptation in Lactobacillus casei BL23 leads to structural changes in the cell wall polymer lipoteichoic acid. Microbiology 2013, 159:2416. 13. Tadmor, K et al. Listeria Monocytogenes MDR transporters are involved in LTA synthesis and triggering innate immunity during infection. Frontiers in cellular and infection microbiology 2014, 4:16.